About Us
Our Mission
Leadership
Partnerships
Careers
Contact Us
Our Science
SCY-247
Ibrexafungerp
Life-threatening Infections
MARIO
Community Infections
Pipeline
Publications and Presentations
Product
News
News
Events
Careers
Investors
Our Science
SCY-247
Ibrexafungerp
Life-threatening Infections
Invasive Fungal Infections
Invasive Candidiasis
Invasive Aspergillosis
MARIO
Community Infections
Vulvovaginal Candidiasis
Recurrent VVC
Pipeline
Publications and Presentations
Our Science
Publications and Presentations
Date
Title
October 2017
Assessment of the
In Vitro
Antifungal Activity of SCY-078 Against a Collection of
C. parapsilosis
Clinical Isolates
S. Barat, D. Angulo, K. Borroto-Esoda, M. Ghannoum
IDWeek 2017
October 2017
SCY-078 Demonstrates Significant Tissue Penetration in Rats and Mice Following Oral or IV Administration
S. Barat, K. Borroto-Esoda, D. Angulo, C. Carruthers
IDWeek 2017
August 2017
The Effect of pH on the
In Vitro
Antifungal Activity of SCY-078
E. Larkin, C. Hager, L. Long, N. Isham, S. Barat, K. Borroto-Esoda, S. Wring, D. Angulo, M. Ghannoum
IDSOG 2017
August 2017
Vaginal Concentrations of SCY-078, a Novel Glucan Synthase Inhibitor, Following Oral Administration in Mice
S. Barat, K. Borroto-Esoda, S. Wring, D. Angulo
IDSOG 2017
June 2017
Assessment of the
In Vitro
Antifungal Activity of SCY-078 Against a Panel of Susceptible and Resistant, Clinical
Candida
Isolates from Europe
K. Borroto-Esoda, S. Birchall, C. B. Moore, D. Angulo
ASM Microbe 2017
June 2017
Lack of an Effect of SCY-078, a Novel Antifungal Agent on QTc Interval in Healthy Subjects
G. Murphy, B. Darpo, T. Marbury, M. Hyman, D. Angulo
ASM Microbe 2017
June 2017
In vitro
Interaction between SCY-078, Echinocandins and Azoles against Susceptible & Resistant
Candida
spp. Determined by the Checkerboard Method
K. Borroto-Esoda, B. Scorneaux, D. Angulo, S. Helou
ASM Microbe
April 2017
Evaluation of Antifungal Activity of SCY-078 in Combination with Other Antifungals Against
Aspergillus
Strains
L. Long, E. Larkin, K. Borroto-Esoda, S. Wring, D. Angulo, M. Ghannoum
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Effect of SCY-078 on the Pharmacokinetics of CYP2C8 substrate (Rosiglitazone) – Results from a Phase 1 Clinical Trial
D. Angulo, G. Atiee, C. Corr, M. Willett, G. Murphy, S. Wring
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Effect of SCY-078 on the Pharmacokinetics of Tacrolimus: Results from a Phase 1 Clinical Drug-Drug Interaction Trial
D. Angulo, G. Atiee, C. Corr, M. Willett, G. Murphy, S. Wring
27th European Congress of Clinical Microbiology and Infectious Diseases
< Prev
Next >
Please ensure Javascript is enabled for purposes of
website accessibility